TeraRecon Neuro

TeraRecon, Inc · K220349 · 2022-08-12

TeraRecon Neuro is an AI-enabled medical device from TeraRecon, Inc, listed by FDA (510(k), K220349) with a decision date of 2022-08-12. Review panel: Radiology.

FDA submission numberK220349
Pathway510(k)
CompanyTeraRecon, Inc
Review panel (specialty)Radiology
FDA decision date2022-08-12
DecisionSubstantially Equivalent
Product codeLLZ
ClassificationSystem, Image Processing, Radiological
Device class2
Regulation number892.2050
Review time (calendar days)186
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from TeraRecon, Inc · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.